Stock listing

KRX:347850 D&D Pharmatech Co., Ltd. (디앤디파마텍) 주가

Follow D&D Pharmatech Co., Ltd. into a list and get an email when it puts out news.

Share price · KRX:347850

₩33,900 KRW -1,900 (-5.3%)

Close on Nov 20, 2026

Past year -61.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩33,450 – ₩35,950 KRWNov 20, 2026
Volume
506,854 sharesNov 20, 2026
Market cap
₩1.55T KRWAt the close on Nov 20, 2026 · price × 45.84M shares outstanding
52-week range
₩33,450 – ₩116,600 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩26.77B KRWMedian day 509,861 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
D&D Pharmatech Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:347850 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩33,900-1,900-5.3%₩35,750₩35,950₩33,450506,854
₩35,800-700-1.9%₩37,000₩39,050₩35,500466,185
₩36,500-1,500-3.9%₩37,500₩38,350₩36,400372,818
₩38,000-2,700-6.6%₩40,900₩41,350₩38,000322,801
₩40,700-1,050-2.5%₩42,100₩44,300₩40,500598,410
₩41,750-1,250-2.9%₩42,600₩44,150₩41,600462,201
₩43,000+2,650+6.6%₩39,650₩44,900₩39,400909,942
₩40,350+2,400+6.3%₩38,750₩40,700₩38,300501,937
₩37,950+200+0.5%₩37,250₩39,850₩35,300644,060
₩37,750-2,800-6.9%₩37,150₩39,150₩36,650691,565
₩40,550+1,700+4.4%₩40,450₩43,450₩39,950821,564
₩38,850-2,150-5.2%₩40,600₩40,600₩35,750933,886
₩41,000-200-0.5%₩40,950₩43,400₩40,200430,449
₩41,200+350+0.9%₩39,800₩41,750₩39,800342,234
₩40,850-850-2.0%₩41,700₩42,450₩39,250449,665
₩41,700-1,200-2.8%₩43,300₩43,450₩40,750357,120
₩42,900+2,100+5.1%₩40,800₩43,600₩40,700638,280
₩40,800+150+0.4%₩41,200₩42,300₩40,050324,860
₩40,650-100-0.2%₩40,450₩42,400₩39,700279,977
₩40,750-350-0.9%₩41,100₩41,400₩39,350402,110
₩41,100-2,200-5.1%₩43,000₩44,200₩40,700378,702
₩43,300+2,700+6.7%₩41,000₩43,300₩40,950497,771
₩40,600-800-1.9%₩40,750₩41,750₩38,750352,787
₩41,400+3,300+8.7%₩37,850₩41,400₩37,300466,409
₩38,100+2,700+7.6%₩35,700₩39,400₩35,650555,753
₩35,400-2,400-6.3%₩35,100₩36,775₩34,500557,243
₩37,800+200+0.5%₩37,650₩39,100₩36,850475,586
₩37,600-2,550-6.4%₩38,500₩38,550₩35,900723,186
₩40,150-2,700-6.3%₩42,500₩44,250₩39,850597,273
₩42,850-3,250-7.0%₩44,800₩45,100₩42,750610,181
₩46,100-1,450-3.0%₩48,000₩48,350₩45,000814,627
₩47,550+4,550+10.6%₩43,200₩48,350₩42,8501,214,711
₩43,000-2,250-5.0%₩45,300₩45,800₩42,750425,458
₩45,250+3,400+8.1%₩41,500₩45,300₩41,050686,793
₩41,850-100-0.2%₩42,200₩43,000₩41,350297,363
₩41,950-1,250-2.9%₩42,650₩42,750₩40,500496,682
₩43,200-1,300-2.9%₩45,150₩45,700₩43,150531,181
₩44,500+1,700+4.0%₩43,300₩45,550₩43,200504,491
₩42,800-1,800-4.0%₩44,800₩45,450₩42,600638,823
₩44,600-700-1.5%₩45,350₩45,400₩44,150419,270
₩45,300-750-1.6%₩46,000₩46,150₩44,700722,479
₩46,05000.0%₩46,800₩47,650₩45,650307,322
₩46,050-600-1.3%₩46,350₩46,350₩44,000352,643
₩46,650+600+1.3%₩46,900₩47,450₩45,650383,272
₩46,050-1,500-3.2%₩46,850₩47,100₩45,000446,460
₩47,550-1,250-2.6%₩47,000₩48,100₩46,700431,467
₩48,800-700-1.4%₩48,750₩48,850₩47,050564,543
₩49,500+200+0.4%₩49,000₩50,750₩48,500569,616
₩49,300-400-0.8%₩49,800₩51,200₩49,250516,785
₩49,700+500+1.0%₩49,250₩50,500₩48,950332,416
₩49,200+700+1.4%₩49,250₩49,800₩48,100428,451
₩48,500-550-1.1%₩49,900₩50,300₩47,850514,626
₩49,050-2,750-5.3%₩50,600₩52,800₩48,800737,131
₩51,800-1,700-3.2%₩53,500₩53,500₩51,000512,867
₩53,500-2,100-3.8%₩54,400₩54,500₩51,500868,173
₩55,600-700-1.2%₩55,700₩56,800₩55,100406,320
₩56,30000.0%₩55,500₩57,900₩55,400675,832
₩56,300+100+0.2%₩57,000₩58,900₩55,500703,281
₩56,200-1,100-1.9%₩56,100₩57,200₩53,500599,132
₩57,300+4,000+7.5%₩53,300₩57,700₩53,200998,128
₩53,300-4,500-7.8%₩56,100₩61,700₩51,7002,654,919
₩57,800-300-0.5%₩61,300₩61,900₩56,0001,032,576

Splits

1 split · KRX:347850 · every price before a split is adjusted for it

DayRatioWhat
4-for-1Split
Ticker
KRX:347850
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

Latest news

All D&D Pharmatech Co., Ltd. news

D&D Pharmatech Co., Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in all · newest Jun 16, 2025 · oldest 2025

Valuation

EV/sales 549× against a median of 13.6×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩1.51T KRW
P/E
Loss
EV/sales
549×
EV/EBITDA
Negative EBITDA
Price/book
11.5×
Gross margin
100.0%
Operating margin
Revenue too small
Net margin
−785.5%
Debt to equity
0.8×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
D&D Pharmatech Co., Ltd. · KRX:347850US$1.15BUS$1.12Bn/a549×n/a11.5×−785.5%0.8×n/a
Mineralys Therapeutics, Inc. · NASDAQ:MLYSUS$1.21BUS$585.1Mn/an/an/a2.4×n/a0.0×1.39
GH Research PLC · NASDAQ:GHRSUS$1.20BUS$841.0Mn/an/an/a3.4×n/a0.0×1.28
Vor Biopharma Inc. · NASDAQ:VORUS$1.18BUS$697.4M0.9×n/an/an/an/an/a1.25
Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A · SZSE:300204US$1.17BUS$1.01Bn/a36.1×n/a3.9×−53.3%0.0×n/a
OPKO Health, Inc. · NASDAQ:OPKUS$1.17BUS$1.26Bn/a2.5×n/a1.0×−29.5%0.4×0.90
CStone Pharmaceuticals · HKEX:2616US$1.16BUS$974.6Mn/a24.1×n/a6.0×−162.1%0.3×n/a
Structure Therapeutics, Inc. · NASDAQ:GPCRUS$1.15B−US$82.92Mn/an/an/a0.9×n/a0.0×1.38
COMPASS Pathways Plc · NASDAQ:CMPSUS$1.14BUS$747.8Mn/an/an/a8.0×n/a0.4×1.65
Ascentage Pharma Group International · HKEX:6855US$1.11BUS$1.14Bn/a13.6×n/a13.3×−216.5%3.8×n/a
Shenzhen Chipscreen Biosciences Co. Ltd. Class A · SSE:688321US$1.10BUS$1.10B102×6.8×n/a2.9×6.6%0.5×n/a
Median of the othersUS$1.16BUS$907.8M51.7×13.6×3.4×−53.3%0.3×1.33

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue4.30B11.4B18.7B610.6M1.36B
Gross profit4.30B11.4B18.7B610.6M1.36B
Research and development25.1B23.3B20.0B47.1B56.8B
Selling, general and administrative2.39B7.53B7.95B9.46B2.35B
Operating income-34.0B-34.2B-8.90B-188.4B-75.7B
Depreciation and amortization5.53B2.23B1.26B2.76B11.9B
EBITDA-28.5B-32.0B-7.64B-185.6B-63.8B
Interest expense470.6M614.8M1.43B2.96B1.01B
Income before tax-24.9B-30.4B4.49B-163.5B-72.0B
Net income-23.6B-28.6B3.93B-136.1B-68.2B
Earnings per share, basic-541.04-2,708.40377.19-13,046.65-1,635.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents32.9B30.0B15.6B25.5B76.0B
Short-term investments200
Receivables3.04B72.6M124.7M11.2M
Current assets51.0B39.8B19.6B33.4B81.7B
Property, plant and equipment7.73B6.42B3.02B
Goodwill2.04B2.09B9.90B9.74B34.8B
Total assets97.5B97.5B79.2B93.6B251.1B
Current liabilities5.42B11.1B7.49B54.9B66.9B
Long-term debt000
Total liabilities18.6B27.4B32.6B84.2B112.8B
Shareholders' equity79.5B70.1B46.6B9.44B132.1B
Shares outstanding43.5M10.6M10.4M10.4M41.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-21.1B-21.8B-9.12B-53.1B-51.9B
Capital spending-64.4M-415.8M-45.2M-718.9M-2.22B
Free cash flow-21.2B-22.2B-9.16B-53.8B-54.2B
Cash from investing-539.5M268.1M-478.9M
Cash from financing36.3B-629.9M1.99B
Share buybacks38.0B147.0M
Change in cash2.87B14.4B-9.86B-50.5B15.3B

Open Financials

Cap table

Built by 6ix from D&D Pharmatech Co., Ltd.’s releases

Common shares
45,837,609
Fully diluted
45,837,609

Fully diluted

LineShares
Common shares45,837,609

Share count over time

CountShares
Nov 22, 202645,837,609

Open Cap table

Shareholders

Open Shareholders

Log in to ask 6ix AI your own questions about D&D Pharmatech Co., Ltd.